Therapeutic plasma and cellular apheresis.
D000744:Anemia, Hemolytic, Autoimmune / Q000628:therapy; D000755:Anemia, Sickle Cell / Q000097:blood / Q000628:therapy; D002469:Cell Separation / Q000295:instrumentation / Q000379:methods*; D003240:Connective Tissue Diseases / Q000628:therapy; D017707:Erythrocyte Transfusion; D005260:Female; D005921:Glomerulonephritis / Q000628:therapy; D006801:Humans; D006949:Hyperlipidemias / Q000628:therapy; D007231:Infant, Newborn; D007937:Leukapheresis; D007938:Leukemia / Q000628:therapy; D009157:Myasthenia Gravis / Q000628:therapy; D010951:Plasma Exchange; D010956:Plasmapheresis / Q000009:adverse effects; D010983:Plateletpheresis; D011086:Polycythemia / Q000628:therapy; D011128:Polyradiculopathy / Q000628:therapy; D011247:Pregnancy; D013922:Thrombocytosis / Q000097:blood / Q000628:therapy